You are here: Home > News & Agenda > Agenda

Agenda

37th World Congress ISH 2018

September 13–17, 2018

Vancouver, Canada

International Society of Hematology (ISH)

Read more

EQALM Symposium 2018

October 18-19, 2018

Zagreb, Croatia

The 2018 EQALM symposium and General Assembly will be held in Zagreb, Croatia on 18-19 October, 2018. Futher details will be published when available.

 EQALM (European Organization for External Quality Assurance Providers in Laboratory Medicine)

Read more

60th ASH Annual Meeting & Exposition

December 1-4, 2018

San Diego, CA

  Mark your calendar for the world’s most comprehensive hematology event of the year, the 60th ASH Annual Meeting and Exposition in sunny San Diego. The meeting will provide an invaluable educational experience and the opportunity to review thousands of scientific abstracts highlighting updates in the hottest topics in hematology. Network with top minds in the field and a global community of more than 25,000 hematology professionals from every subspecialty.

American Society of Hematology (ASH)

Read more

World congress on rare diseases

December 5-7, 2018

Dubai, UAE

 Rare Diseases Congress is giving a worldwide stage to analysts that afford new insights into the concealed rare diseases. This conference will feature a global audience of scientific leaders, academia and health care professionals, and Orphan Drugs experts who are going to discuss today’s emerging treatments and diagnostics. It is designed to provide an educational forum that stimulates clinical, research, government and patient communities to create a coordinated and comprehensive approach for advancing the implementation of research, clinical care, care delivery coordination and other public health interventions critical to improved outcomes in Rare Diseases.

 Conferenceseries LLC Ltd

Read more

International conference on ERYTHROPOIESIS CONTROL AND INEFFECTIVE ERYTHROPOIESIS: FROM BENCH TO BEDSIDE

March 15-17, 2019

Budapest, Hungary

 The main objective of this conference is to translate recent, novel data from basic research on the origin and developmental control of mega/erythroid progenitors in haematopoiesis to clinical practice. The meeting is structured with the specific aim to be translational “from bench to bedside”, and to involve participants in lively interactive discussions. It offers a unique opportunity to discuss basic science in a clinical context. This approach will notably involve the presentation and discussion of challenging clinical cases. The two and half day programme includes 9 sessions that will alternate basic science and clinical practice, with a focus on specific diseases such as CDAs, thalassaemia, SCD, haemolytic anaemias and MDS

European School of Haematology (ESH) 

Read more

Copyright © 2002 - 2018 Enerca

Co-funded by the Health Programme of the European Union.